Kevin J. Mcnamara Sells 1,000 Shares of Chemed Co. (NYSE:CHE) Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. The trade was a 0.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Chemed Stock Down 0.7 %

Shares of Chemed stock opened at $614.41 on Thursday. The company has a 50-day simple moving average of $577.76 and a two-hundred day simple moving average of $567.62. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $639.61. The stock has a market capitalization of $8.99 billion, a price-to-earnings ratio of 31.05, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio is currently 10.05%.

Hedge Funds Weigh In On Chemed

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC raised its stake in Chemed by 17.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 1,382 shares of the company’s stock valued at $732,000 after purchasing an additional 207 shares in the last quarter. Centaurus Financial Inc. lifted its holdings in shares of Chemed by 5.6% during the 4th quarter. Centaurus Financial Inc. now owns 5,354 shares of the company’s stock worth $2,837,000 after acquiring an additional 283 shares during the period. Cim LLC boosted its position in shares of Chemed by 2.2% during the 4th quarter. Cim LLC now owns 2,008 shares of the company’s stock worth $1,064,000 after acquiring an additional 44 shares in the last quarter. Jefferies Financial Group Inc. increased its stake in Chemed by 335.0% in the fourth quarter. Jefferies Financial Group Inc. now owns 1,453 shares of the company’s stock valued at $770,000 after acquiring an additional 1,119 shares during the last quarter. Finally, United Advisor Group LLC lifted its stake in Chemed by 25.1% during the fourth quarter. United Advisor Group LLC now owns 807 shares of the company’s stock worth $428,000 after purchasing an additional 162 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CHE has been the subject of a number of research analyst reports. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada upped their price objective on Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a report on Friday, March 14th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.